Latest / Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Weekly Insulin Icodec Now Available for Type 2 Diabetes
Once-weekly basal insulin therapy has moved from clinical trial data to pharmacy shelves, offering clinicians a new option for patients who struggle with the daily burden of insulin injections. The shift addresses a persistent adherence problem in basal insulin therapy, where missed or inconsistent daily dosing undermines glycemic control.In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss the pharmacy launch of insulin icodec (Awiqli), the first once-weekly basal insulin now available in the United States.The approval rests on data from…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.